Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 382

1.

High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation.

Tsang ES, Villa D, Loscocco F, Visani G, Power M, Guiducci B, Clissa C, Song K, Toze C, Abou Mourad Y, Sutherland H, Sanford D, Nantel SH, Sehn LH, Scott DW, Savage KJ, Connors JM, Gerrie AS, Isidori A.

Bone Marrow Transplant. 2018 Aug 31. doi: 10.1038/s41409-018-0328-9. [Epub ahead of print] No abstract available.

PMID:
30171222
2.

Serum Homocysteine Levels in Men with and without Erectile Dysfunction: A Systematic Review and Meta-Analysis.

Sansone A, Cignarelli A, Sansone M, Romanelli F, Corona G, Gianfrilli D, Isidori A, Giorgino F, Lenzi A.

Int J Endocrinol. 2018 Aug 7;2018:7424792. doi: 10.1155/2018/7424792. eCollection 2018. Review.

3.

Glycometabolic Alterations in Secondary Adrenal Insufficiency: Does Replacement Therapy Play a Role?

Graziadio C, Hasenmajer V, Venneri MA, Gianfrilli D, Isidori AM, Sbardella E.

Front Endocrinol (Lausanne). 2018 Aug 3;9:434. doi: 10.3389/fendo.2018.00434. eCollection 2018. Review.

4.

Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors.

Di Giacinto P, Rota F, Rizza L, Campana D, Isidori A, Lania A, Lenzi A, Zuppi P, Baldelli R.

Int J Endocrinol. 2018 Jul 2;2018:8126087. doi: 10.1155/2018/8126087. eCollection 2018. Review.

5.

Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients.

Palandri F, Catani L, Bonifacio M, Benevolo G, Heidel F, Palumbo GA, Crugnola M, Abruzzese E, Bartoletti D, Polverelli N, Bergamaschi M, Tiribelli M, Iurlo A, Breccia M, Cavazzini F, Tieghi A, Binotto G, Isidori A, Martino B, D'Adda M, Bosi C, Sabattini E, Vitolo U, Aversa F, Ibatici A, Lemoli RM, Sgherza N, Cuneo A, Martinelli G, Semenzato G, Cavo M, Vianelli N, Sapienza MR, Latagliata R.

Br J Haematol. 2018 Jul 16. doi: 10.1111/bjh.15497. [Epub ahead of print]

PMID:
30010187
6.

Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach.

Isidori A, Loscocco F, Ciciarello M, Corradi G, Lecciso M, Ocadlikova D, Parisi S, Salvestrini V, Amadori S, Visani G, Curti A.

Cancers (Basel). 2018 Jun 22;10(7). pii: E211. doi: 10.3390/cancers10070211. Review.

7.

The CATCH checklist to investigate adult-onset hypogonadism.

Defeudis G, Mazzilli R, Gianfrilli D, Lenzi A, Isidori AM.

Andrology. 2018 Jun 10. doi: 10.1111/andr.12506. [Epub ahead of print] Review.

PMID:
29888533
8.

The Short Synacthen (Corticotropin) Test Can Be Used to Predict Recovery of Hypothalamo-Pituitary-Adrenal Axis Function.

Pofi R, Feliciano C, Sbardella E, Argese N, Woods CP, Grossman AB, Jafar-Mohammadi B, Gleeson H, Lenzi A, Isidori AM, Tomlinson JW.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):3050-3059. doi: 10.1210/jc.2018-00529.

PMID:
29846658
9.

Circadian Rhythm of Glucocorticoid Administration Entrains Clock Genes in Immune Cells: A DREAM Trial Ancillary Study.

Venneri MA, Hasenmajer V, Fiore D, Sbardella E, Pofi R, Graziadio C, Gianfrilli D, Pivonello C, Negri M, Naro F, Grossman AB, Lenzi A, Pivonello R, Isidori AM.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):2998-3009. doi: 10.1210/jc.2018-00346.

PMID:
29846607
10.

Chronic phosphodiesterase type 5 inhibition has beneficial effects on subcutaneous adipose tissue plasticity in type 2 diabetic mice.

Fiore D, Gianfrilli D, Cardarelli S, Naro F, Lenzi A, Isidori AM, Venneri MA.

J Cell Physiol. 2018 May 24. doi: 10.1002/jcp.26796. [Epub ahead of print]

PMID:
29797572
11.

Genetic profiling in acute myeloid leukemia: a path to predicting treatment outcome.

Visani G, Loscocco F, Isidori A, Piccaluga PP.

Expert Rev Hematol. 2018 Jun;11(6):455-461. doi: 10.1080/17474086.2018.1475225. Epub 2018 May 24.

PMID:
29792762
12.

Iron toxicity - Its effect on the bone marrow.

Isidori A, Borin L, Elli E, Latagliata R, Martino B, Palumbo G, Pilo F, Loscocco F, Visani G, Cianciulli P.

Blood Rev. 2018 Apr 13. pii: S0268-960X(17)30150-9. doi: 10.1016/j.blre.2018.04.004. [Epub ahead of print] Review.

PMID:
29699840
13.

Sildenafil normalizes MALAT1 level in diabetic cardiomyopathy.

Bacci L, Barbati SA, Colussi C, Aiello A, Isidori AM, Grassi C, Pontecorvi A, Farsetti A, Gaetano C, Nanni S.

Endocrine. 2018 Oct;62(1):259-262. doi: 10.1007/s12020-018-1599-z. Epub 2018 Apr 24. No abstract available.

PMID:
29691810
14.

Mortality data from the European Adrenal Insufficiency Registry-Patient characterization and associations.

Quinkler M, Ekman B, Zhang P, Isidori AM, Murray RD; EU-AIR Investigators.

Clin Endocrinol (Oxf). 2018 Jul;89(1):30-35. doi: 10.1111/cen.13609. Epub 2018 Apr 22.

PMID:
29682773
15.

Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice.

Breccia M, Abruzzese E, Castagnetti F, Bonifacio M, Gangemi D, Sorà F, Iurlo A, Luciano L, Gozzini A, Gentile M, Bocchia M, Luzi D, Maggi A, Sgherza N, Isidori A, Crugnola M, Pregno P, Scortechini AR, Capodanno I, Pizzuti M, Foà R.

Ann Hematol. 2018 Sep;97(9):1577-1580. doi: 10.1007/s00277-018-3337-2. Epub 2018 Apr 19.

PMID:
29675611
16.

Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients.

Polverelli N, Palumbo GA, Binotto G, Abruzzese E, Benevolo G, Bergamaschi M, Tieghi A, Bonifacio M, Breccia M, Catani L, Tiribelli M, D'Adda M, Sgherza N, Isidori A, Cavazzini F, Martino B, Latagliata R, Crugnola M, Heidel F, Bosi C, Ibatici A, Soci F, Penna D, Scaffidi L, Aversa F, Lemoli RM, Vitolo U, Cuneo A, Russo D, Cavo M, Vianelli N, Palandri F.

Hematol Oncol. 2018 Apr 6. doi: 10.1002/hon.2509. [Epub ahead of print]

PMID:
29624703
17.

Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-analysis of Prospective Interventional Studies.

Cozzolino A, Feola T, Simonelli I, Puliani G, Pozza C, Giannetta E, Gianfrilli D, Pasqualetti P, Lenzi A, Isidori AM.

J Clin Endocrinol Metab. 2018 Mar 23. doi: 10.1210/jc.2017-02566. [Epub ahead of print]

PMID:
29590371
18.

Once-daily, modified-release hydrocortisone in patients with adrenal insufficiency - Authors' reply.

Isidori AM, Hasenmajer V, Venneri MA.

Lancet Diabetes Endocrinol. 2018 Apr;6(4):270-271. doi: 10.1016/S2213-8587(18)30040-8. No abstract available.

PMID:
29571509
19.

Kitcre knock-in mice fail to fate-map cardiac stem cells.

Vicinanza C, Aquila I, Cianflone E, Scalise M, Marino F, Mancuso T, Fumagalli F, Giovannone ED, Cristiano F, Iaccino E, Marotta P, Torella A, Latini R, Agosti V, Veltri P, Urbanek K, Isidori AM, Saur D, Indolfi C, Nadal-Ginard B, Torella D.

Nature. 2018 Mar 21;555(7697):E1-E5. doi: 10.1038/nature25771. No abstract available.

PMID:
29565363
20.

Testosterone replacement therapy: For whom, when and how?

Tsametis CP, Isidori AM.

Metabolism. 2018 Sep;86:69-78. doi: 10.1016/j.metabol.2018.03.007. Epub 2018 Mar 9. Review.

PMID:
29530796
21.

Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas.

Sbardella E, Minnetti M, D'Aluisio D, Rizza L, Di Giorgio MR, Vinci F, Pofi R, Giannetta E, Venneri MA, Vestri A, Morelli S, Lenzi A, Isidori AM.

Eur J Endocrinol. 2018 May;178(5):501-511. doi: 10.1530/EJE-17-0986. Epub 2018 Mar 6.

PMID:
29510982
22.

Critical role of phosphodiesterase 2A in mouse congenital heart defects.

Assenza MR, Barbagallo F, Barrios F, Cornacchione M, Campolo F, Vivarelli E, Gianfrilli D, Auletta L, Soricelli A, Isidori AM, Lenzi A, Pellegrini M, Naro F.

Cardiovasc Res. 2018 May 1;114(6):830-845. doi: 10.1093/cvr/cvy030.

PMID:
29409032
23.

Charge Density Waves in Graphite: Towards the Magnetic Ultraquantum Limit.

Arnold F, Isidori A, Kampert E, Yager B, Eschrig M, Saunders J.

Phys Rev Lett. 2017 Sep 29;119(13):136601. doi: 10.1103/PhysRevLett.119.136601. Epub 2017 Sep 26.

PMID:
29341727
24.

Smoke, alcohol and drug addiction and male fertility.

Sansone A, Di Dato C, de Angelis C, Menafra D, Pozza C, Pivonello R, Isidori A, Gianfrilli D.

Reprod Biol Endocrinol. 2018 Jan 15;16(1):3. doi: 10.1186/s12958-018-0320-7. Review.

25.

USPIO-labeling in M1 and M2-polarized macrophages: An in vitro study using a clinical magnetic resonance scanner.

Zini C, Venneri MA, Miglietta S, Caruso D, Porta N, Isidori AM, Fiore D, Gianfrilli D, Petrozza V, Laghi A.

J Cell Physiol. 2018 Aug;233(8):5823-5828. doi: 10.1002/jcp.26360. Epub 2018 Feb 27.

PMID:
29230805
26.

Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.

Isidori AM, Venneri MA, Graziadio C, Simeoli C, Fiore D, Hasenmajer V, Sbardella E, Gianfrilli D, Pozza C, Pasqualetti P, Morrone S, Santoni A, Naro F, Colao A, Pivonello R, Lenzi A.

Lancet Diabetes Endocrinol. 2018 Mar;6(3):173-185. doi: 10.1016/S2213-8587(17)30398-4. Epub 2017 Dec 8.

PMID:
29229498
27.

MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine.

Visani G, Loscocco F, Ruzzo A, Galimberti S, Graziano F, Voso MT, Giacomini E, Finelli C, Ciabatti E, Fabiani E, Barulli S, Volpe A, Magro D, Piccaluga P, Fuligni F, Vignetti M, Fazi P, Piciocchi A, Gabucci E, Rocchi M, Magnani M, Isidori A.

Pharmacogenomics J. 2018 May 22;18(3):444-449. doi: 10.1038/tpj.2017.48. Epub 2017 Dec 5.

PMID:
29205204
28.

Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).

Sbardella E, Isidori AM, Arnaldi G, Arosio M, Barone C, Benso A, Berardi R, Capasso G, Caprio M, Ceccato F, Corona G, Della Casa S, De Nicola L, Faustini-Fustini M, Fiaccadori E, Gesualdo L, Gori S, Lania A, Mantovani G, Menè P, Parenti G, Pinto C, Pivonello R, Razzore P, Regolisti G, Scaroni C, Trepiccione F, Lenzi A, Peri A; the: Fluid and Electrolyte Disorders Club of the Italian Society of Endocrinology; Italian Society of Nephrology; and Italian Association of Medical Oncology.

J Endocrinol Invest. 2018 Jan;41(1):3-19. doi: 10.1007/s40618-017-0776-x. Epub 2017 Nov 20. No abstract available.

PMID:
29152673
29.

The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia.

Galimberti S, Bucelli C, Arrigoni E, Baratè C, Grassi S, Ricci F, Guerrini F, Ciabatti E, Fava C, D'Avolio A, Fontanelli G, Cambrin GR, Isidori A, Loscocco F, Caocci G, Greco M, Bocchia M, Aprile L, Gozzini A, Scappini B, Cattaneo D, Scortechini AR, La Nasa G, Bosi A, Leoni P, Danesi R, Saglio G, Visani G, Cortelezzi A, Petrini M, Iurlo A, Di Paolo A.

Oncotarget. 2017 Sep 30;8(50):88021-88033. doi: 10.18632/oncotarget.21406. eCollection 2017 Oct 20.

30.

Deregulation of the growth hormone/insulin-like growth factor-1 axis in adults with cystic fibrosis.

Pascucci C, De Biase RV, Savi D, Quattrucci S, Isidori AM, Lubrano C, Gnessi L, Lenzi A.

J Endocrinol Invest. 2018 May;41(5):591-596. doi: 10.1007/s40618-017-0784-x. Epub 2017 Nov 2.

PMID:
29098662
31.

Model of Murine Ventricular Cardiac Tissue for In Vitro Kinematic-Dynamic Studies of Electromagnetic and β-Adrenergic Stimulation.

Fassina L, Cornacchione M, Pellegrini M, Mognaschi ME, Gimmelli R, Isidori AM, Lenzi A, Magenes G, Naro F.

J Healthc Eng. 2017;2017:4204085. doi: 10.1155/2017/4204085. Epub 2017 Aug 8.

32.

Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study.

Visani G, Ferrara F, Di Raimondo F, Loscocco F, Fuligni F, Paolini S, Zammit V, Spina E, Rocchi M, Visani A, Piccaluga PP, Isidori A.

Leuk Res. 2017 Nov;62:77-83. doi: 10.1016/j.leukres.2017.09.019. Epub 2017 Sep 25.

33.

Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH).

Bonomi M, Vezzoli V, Krausz C, Guizzardi F, Vezzani S, Simoni M, Bassi I, Duminuco P, Di Iorgi N, Giavoli C, Pizzocaro A, Russo G, Moro M, Fatti L, Ferlin A, Mazzanti L, Zatelli MC, Cannavò S, Isidori AM, Pincelli AI, Prodam F, Mancini A, Limone P, Tanda ML, Gaudino R, Salerno M, Francesca P, Maghnie M, Maggi M, Persani L; Italian Network on Central Hypogonadism.

Eur J Endocrinol. 2018 Jan;178(1):23-32. doi: 10.1530/EJE-17-0065. Epub 2017 Sep 7.

PMID:
28882981
34.

Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours.

Manganaro L, Saldari M, Pozza C, Vinci V, Gianfrilli D, Greco E, Franco G, Sergi ME, Scialpi M, Catalano C, Isidori AM.

Eur Radiol. 2018 Feb;28(2):554-564. doi: 10.1007/s00330-017-5013-7. Epub 2017 Aug 30.

PMID:
28856410
35.

Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling.

Tripodo C, Burocchi A, Piccaluga PP, Chiodoni C, Portararo P, Cappetti B, Botti L, Gulino A, Isidori A, Liso A, Visani G, Martelli MP, Falini B, Pandolfi PP, Colombo MP, Sangaletti S.

Cancer Res. 2017 Jul 1;77(13):3685-3699. doi: 10.1158/0008-5472.CAN-17-1098. Epub 2017 May 23.

36.

Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study.

Palandri F, Tiribelli M, Benevolo G, Tieghi A, Cavazzini F, Breccia M, Bergamaschi M, Sgherza N, Polverelli N, Crugnola M, Isidori A, Binotto G, Heidel FH, Buccisano F, Martino B, Latagliata R, Spinsanti M, Kallenberg L, Palumbo GA, Abruzzese E, Scaffidi L, Cuneo A, Cavo M, Vianelli N, Bonifacio M.

Hematol Oncol. 2018 Feb;36(1):285-290. doi: 10.1002/hon.2429. Epub 2017 May 17.

PMID:
28512865
37.

Routine genetic screening with a multi-gene panel in patients with pheochromocytomas.

Sbardella E, Cranston T, Isidori AM, Shine B, Pal A, Jafar-Mohammadi B, Sadler G, Mihai R, Grossman AB.

Endocrine. 2018 Jan;59(1):175-182. doi: 10.1007/s12020-017-1310-9. Epub 2017 May 5.

PMID:
28477304
38.

Profiling of selenium absorption and accumulation in healthy subjects after prolonged L-selenomethionine supplementation.

Di Dato C, Gianfrilli D, Greco E, Astolfi M, Canepari S, Lenzi A, Isidori AM, Giannetta E.

J Endocrinol Invest. 2017 Nov;40(11):1183-1190. doi: 10.1007/s40618-017-0663-5. Epub 2017 Apr 9.

PMID:
28393316
39.

Transcription Factor CREM Mediates High Glucose Response in Cardiomyocytes and in a Male Mouse Model of Prolonged Hyperglycemia.

Barbati SA, Colussi C, Bacci L, Aiello A, Re A, Stigliano E, Isidori AM, Grassi C, Pontecorvi A, Farsetti A, Gaetano C, Nanni S.

Endocrinology. 2017 Jul 1;158(7):2391-2405. doi: 10.1210/en.2016-1960.

PMID:
28368536
40.

Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7.

Pofi R, Fiore D, De Gaetano R, Panio G, Gianfrilli D, Pozza C, Barbagallo F, Xiang YK, Giannakakis K, Morano S, Lenzi A, Naro F, Isidori AM, Venneri MA.

Sci Rep. 2017 Mar 15;7:44584. doi: 10.1038/srep44584.

41.

Identification of murine phosphodiesterase 5A isoforms and their functional characterization in HL-1 cardiac cell line.

Campolo F, Zevini A, Cardarelli S, Monaco L, Barbagallo F, Pellegrini M, Cornacchione M, Di Grazia A, De Arcangelis V, Gianfrilli D, Giorgi M, Lenzi A, Isidori AM, Naro F.

J Cell Physiol. 2018 Jan;233(1):325-337. doi: 10.1002/jcp.25880. Epub 2017 May 18.

PMID:
28247930
42.

Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: A case report.

Giannetta E, Isidori AM, Durante C, Di Gioia C, Longo F, Tombolini V, Bulzonetti N, Graziadio C, Pofi R, Gianfrilli D, Verrienti A, Carletti R, Filetti S, Lenzi A, Baroli A.

Medicine (Baltimore). 2017 Feb;96(6):e5621. doi: 10.1097/MD.0000000000005621.

43.

Hypothyroidism and Nephrotic Syndrome: Why, When and How to Treat.

Mario FD, Pofi R, Gigante A, Rivoli L, Rosato E, Isidori AM, Cianci R, Barbano B.

Curr Vasc Pharmacol. 2017;15(5):398-403. doi: 10.2174/1570161115999170207114706. Review.

PMID:
28176633
44.

Sildenafil Prevents Podocyte Injury via PPAR-γ-Mediated TRPC6 Inhibition.

Sonneveld R, Hoenderop JG, Isidori AM, Henique C, Dijkman HB, Berden JH, Tharaux PL, van der Vlag J, Nijenhuis T.

J Am Soc Nephrol. 2017 May;28(5):1491-1505. doi: 10.1681/ASN.2015080885. Epub 2016 Nov 28.

45.

Gender-related differences in pulmonary arterial hypertension targeted drugs administration.

Marra AM, Benjamin N, Eichstaedt C, Salzano A, Arcopinto M, Gargani L, D Alto M, Argiento P, Falsetti L, Di Giosia P, Isidori AM, Ferrara F, Bossone E, Cittadini A, Grünig E.

Pharmacol Res. 2016 Dec;114:103-109. doi: 10.1016/j.phrs.2016.10.018. Epub 2016 Oct 19. Review.

PMID:
27771466
46.

Environmental nanoparticles are significantly over-expressed in acute myeloid leukemia.

Visani G, Manti A, Valentini L, Canonico B, Loscocco F, Isidori A, Gabucci E, Gobbi P, Montanari S, Rocchi M, Papa S, Gatti AM.

Leuk Res. 2016 Nov;50:50-56. doi: 10.1016/j.leukres.2016.09.004. Epub 2016 Sep 3.

PMID:
27669365
47.

Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction.

Salzano A, Marra AM, Ferrara F, Arcopinto M, Bobbio E, Valente P, Polizzi R, De Vincentiis C, Matarazzo M, Saldamarco L, Saccà F, Napoli R, Monti MG, D'Assante R, Isidori AM, Isgaard J, Ferrara N, Filardi PP, Perticone F, Vigorito C, Bossone E, Cittadini A; T.O.S.CA. investigators.

Int J Cardiol. 2016 Dec 15;225:1-3. doi: 10.1016/j.ijcard.2016.09.085. Epub 2016 Sep 26. No abstract available.

PMID:
27689528
48.

Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).

Maggi M, Wu FC, Jones TH, Jackson G, Behre HM, Hackett G, Martin-Morales A, Balercia G, Dobs AS, Arver ST, Maggio M, Cunningham GR, Isidori AM, Quinton R, Wheaton OA, Siami FS, Rosen RC; RHYME Investigators.

Int J Clin Pract. 2016 Oct;70(10):843-852. doi: 10.1111/ijcp.12876.

PMID:
27774779
49.

Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes.

Isidori AM, Venneri MA, Fiore D.

J Endocrinol Invest. 2016 Nov;39(11):1235-1246. Epub 2016 Jun 25. Review.

PMID:
27344309
50.

Contralateral interlaminar approach for intraforaminal lumbar degenerative disease with special emphasis on L5-S1 level: A technical note.

Zekaj E, Menghetti C, Saleh C, Isidori A, Bona AR, Aimar E, Servello D.

Surg Neurol Int. 2016 Sep 21;7:88. eCollection 2016.

Supplemental Content

Loading ...
Support Center